Publicaciones en las que colabora con LUIS FELIPE CALLADO HERNANDO (118)

2024

  1. Next-Generation Proteomics of Brain Extracellular Vesicles in Schizophrenia Provide New Clues on the Altered Molecular Connectome

    Biomedicines, Vol. 12, Núm. 1

  2. Permissive epigenetic regulatory mechanisms at the histone level are enhanced in postmortem dorsolateral prefrontal cortex of individuals with schizophrenia

    Journal of Psychiatry and Neuroscience, Vol. 49, Núm. 1, pp. E35-E44

2023

  1. Agonistic properties of a series of psychotropic drugs at 5-HT1A receptors in rat and human brain membranes determined by [35S]GTPγS binding assay

    Pharmacological Reports, Vol. 75, Núm. 2, pp. 266-275

  2. Antipsychotic-induced epigenomic reorganization in frontal cortex of individuals with schizophrenia

    eLife, Vol. 12

  3. GRM2 eta GRM3 geneen adierazpenaren ebaluazioa subjektu eskizofrenikoen postmortem garuneko kortex aurrefrontalean

    Osasun zientziak: V. Ikergazte Nazioarteko Ikerteta Euskaraz. 2023eko maitzaren 17, 18 eta 19 Donostia, Euskal Herria.

  4. Isolation and Differentiation of Neurons and Glial Cells from Olfactory Epithelium in Living Subjects

    Molecular Neurobiology, Vol. 60, Núm. 8, pp. 4472-4487

  5. Pathogenic Mis-splicing of CPEB4 in Schizophrenia

    Biological Psychiatry, Vol. 94, Núm. 4, pp. 341-351

2022

  1. Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients

    Addiction Biology, Vol. 27, Núm. 6

  2. Glucocorticoid receptor dysregulation underlies 5-HT2AR-dependent synaptic and behavioral deficits in a mouse neurodevelopmental disorder model

    Journal of Biological Chemistry, Vol. 298, Núm. 11

2021

  1. 5-HT2A receptor- and M1 muscarinic acetylcholine receptor-mediated activation of Gαq/11 in postmortem dorsolateral prefrontal cortex of opiate addicts

    Pharmacological Reports, Vol. 73, Núm. 4, pp. 1155-1163

  2. 5-HT2A receptor-mediated Gαq/11 activation in psychiatric disorders: A postmortem study

    World Journal of Biological Psychiatry, Vol. 22, Núm. 7, pp. 505-515

  3. Characterization of dopamine D2 receptor coupling to G proteins in postmortem brain of subjects with schizophrenia

    Pharmacological Reports, Vol. 73, Núm. 4, pp. 1136-1146

  4. Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment

    Translational Psychiatry, Vol. 11, Núm. 1

  5. In Vivo Brain Microdialysis of Monoamines

    Neuromethods (Humana Press Inc.), pp. 489-512

  6. Opposite alterations of 5­HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile

    Translational Psychiatry, Vol. 11, Núm. 1

  7. Spinophilin expression in postmortem prefrontal cortex of schizophrenic subjects: Effects of antipsychotic treatment

    European Neuropsychopharmacology, Vol. 42, pp. 12-21

  8. α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects

    European Neuropsychopharmacology, Vol. 52, pp. 3-11

2020

  1. Calcium-binding proteins are altered in the cerebellum in schizophrenia

    PloS one, Vol. 15, Núm. 7, pp. e0230400

  2. Cannabis.

    Manual de trastornos adictivos (J. Belarmino Bobes, M. Casas y M. Gutiérrez), pp. 559-567

  3. Functional coupling of M1 muscarinic acetylcholine receptor to Gαq/11 in dorsolateral prefrontal cortex from patients with psychiatric disorders: a postmortem study

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 270, Núm. 7, pp. 869-880